Related Experiment Video
Updated: May 2, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Sudden cardiac death in patients with nonischemic cardiomyopathy
Brian P Betensky1, Sanjay Dixit2
1Division of Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Insights
Sudden cardiac death (SCD) risk is significant in nonischemic cardiomyopathies. This review explores the substrate for ventricular arrhythmias and SCD risk factors in dilated, hypertrophic, and arrhythmogenic right ventricular cardiomyopathies.
Area of Science:
- Cardiology
- Electrophysiology
- Sudden Cardiac Death Research
Background:
- Sudden cardiac death (SCD) is a major global health concern.
- While often linked to coronary heart disease, SCD risk is also significant in patients without ischemic heart disease.
- Nonischemic cardiomyopathies, including dilated, hypertrophic, and arrhythmogenic right ventricular types, are strongly associated with SCD and ventricular arrhythmias.
Purpose of the Study:
- To review the current understanding of the arrhythmogenic substrate in nonischemic cardiomyopathies.
- To highlight features associated with increased SCD risk in these conditions.
- To discuss challenges in risk stratification and treatment of ventricular arrhythmias.
Main Methods:
- Literature review of studies on nonischemic cardiomyopathies and SCD.
- Analysis of anatomic and electrophysiologic substrates for ventricular arrhythmias.
- Evaluation of risk stratification tools and clinical features.
Main Results:
- Nonischemic cardiomyopathies present unique challenges for identifying SCD risk.
- Understanding the specific substrate in each cardiomyopathy is crucial for risk assessment.
- Optimal risk stratification strategies remain an area of active investigation.
Conclusions:
- Ventricular arrhythmias and SCD are significant risks in nonischemic cardiomyopathies.
- Further research is needed to refine risk stratification and management strategies.
- Targeted approaches to the arrhythmogenic substrate may improve outcomes.
Abstract:
Sudden cardiac death (SCD) is an important cause of mortality worldwide. Although SCD is most often associated with coronary heart disease, the risk of SCD in patients without ischemic heart disease is well-established. Nonischemic cardiomyopathies, including idiopathic dilated cardiomyopathy, hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy represent three unique disease entities that have been shown to be highly associated with SCD and ventricular arrhythmias. A variety of risk stratification tools have been investigated, although the optimal strategy remains unknown. Identification of the arrhythmogenic substrate and treatment of ventricular arrhythmias in these subgroups can be challenging. Herein, we aim to discuss the current understanding of the anatomic and electrophysiologic substrate underlying ventricular arrhythmias and highlight features that may be associated with a higher risk of SCD in these 3 conditions.
More Related Videos
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction Cardiac Emergencies
Myocarditis I: Introduction